The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIxico Regulatory News (IXI)

Share Price Information for Ixico (IXI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 7.625
Bid: 7.50
Ask: 7.75
Change: 0.00 (0.00%)
Spread: 0.25 (3.333%)
Open: 7.625
High: 7.625
Low: 7.625
Prev. Close: 7.625
IXI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

European research to tackle dementia

9 Mar 2016 09:30

RNS Number : 4684R
IXICO plc
09 March 2016
 

European research to tackle the triple challenge of dementia, hearing and vision impairment

 

The combined impact of dementia, age-related hearing and vision impairment is to be investigated by a new multi-million European research consortium led by the University of Manchester.

 

Seven in ten Europeans over the age of 65 suffer from either sight or hearing problems and over two thirds suffer from depression or dementia. When combined together the cumulative impact of these dual or triple impairments is far greater than the individual conditions. The scale of combined sensory and cognitive problems is substantial but poorly understood.

 

The five year SENSE-Cog project, led by the University of Manchester, has been funded with €6.5m from the European Commission's Horizon 2020 research programme. The project aims to investigate this combined impact and develop new tools that could improve quality of life and optimise health and social care budgets across Europe.

 

Dr Iracema Leroi, an academic psychiatrist from The University of Manchester, who is the lead researcher on the project, said: "In combination these problems have a much greater effect than each one individually. Imagine if you have dementia which affects your memory or interferes with your recognition of familiar people. When you add visual impairment to that, you can understand why those affected may experience even greater cognitive difficulty or even experience altered behaviour such as agitation or hallucinations.

 

The burden on carers - often family members - is also increased as they are required to do much more on a daily basis and we see a greater number of these suffering from burn-out."

 

The project seeks to define the scale of the challenges so that authorities across the continent can allocate resources more optimally. At the same time, researchers will also develop online tests, guides and multi-lingual training manuals to help medical professionals diagnose and treat the combined problems more effectively.

 

Minority groups are particularly disadvantaged with respect to diagnosis and treatment of mental and sensory problems, so researchers will be seeking out people from these groups to participate in the research.

 

The programme will also trial an intervention of at-home support for people with dual- and triple-impairments. This will be supported by specialist sensory therapists based at Central Manchester University Hospitals NHS Foundation Trust and will focus around pragmatic solutions to support both the affected person and their carer.

 

Dr Piers Dawes, a University of Manchester audiologist and co-lead of the SENSE-Cog project said: "Millions of people in the UK and wider EU are affected by this combination of problems and it's only going to get more prevalent as the population ages. That's why we have to understand the scale of the problem and then equip the public, carers and health care workers with the tools they need to deal with it. If we could reduce disability due to hearing and vision impairment, there is huge potential to improve mental well-being and even delay the deterioration of dementia."

 

ENDS

 

Notes to editors

 

Interviews on request

Follow @UomNews on Twitter

The latest media videos are on our YouTube page

The latest news and coverage on Google+

A record of the University in the news is on our Scoop.it page

 

The consortium for SENSE-Cog:

(1) THE UNIVERSITY OF MANCHESTER (UK, Coordinator)

(2) European University Cyprus (Cyprus)

(3) THE MANCHESTER METROPOLITAN UNIVERSITY (UK)

(4) ETHNIKO KAI KAPODISTRIAKO PANEPISTIMIO ATHINON (Greece)

(5) UNIVERSITE DE NICE SOPHIA ANTIPOLIS (France)

(6) UNIVERSITE DE BORDEAUX (France)

(7) Erasmus University Medical Center Rotterdam (Netherlands)

(8) UNIVERSITETET I TROMSOE (Norway)

(9) Katholische Hochschule Freiburg gGmbH (Germany)

(10) Dementia Pal Ltd (UK industrial partner)

(11) IXICO TECHNOLOGIES LIMITED (UK industrial partner)

(12) Starkey Laboratories (US industrial partner)

(13) HORTECH GGMBH (Germany)

(14) ESSILOR INTERNATIONAL SA (Industrial partner)

(15) GABO:MI GESELLSCHAFT FUR ABLAUFORGANISATION:MILLIARIUM MBH & CO KG (German project management partner, SME)

(16) Centre Hospitalier Universitaire de Nice (France)

(17) UNIVERSITY OF CYPRUS (Cyprus)

 

 

Media enquiries to:

Jamie Brown

Media Relations Officer

The University of Manchester

Tel: 0161 2758383

Mob: 07887 561318

Email: jamie.brown@manchester.ac.uk

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAVVLFBQXFXBBB
Date   Source Headline
7th May 20247:00 amRNSNotice of half year results
15th Apr 20247:00 amRNSLife Molecular Imaging – Neuraceq Supply Agreement
3rd Apr 20247:00 amRNSImeka Collaboration Agreement
13th Mar 20247:00 amRNSTrading Update
29th Jan 202412:00 pmRNSHolding(s) in Company
25th Jan 20244:00 pmRNSResult of AGM
12th Jan 20249:35 amRNSDirectorate Change
27th Dec 20237:00 amRNSUpdate regarding Nominated Adviser and Broker
15th Dec 20237:00 amRNSChange of Auditor
5th Dec 20237:00 amRNSFinancial Results for year ended 30 September 2023
27th Nov 20237:00 amRNSNotice of Results and Investor Presentation
5th Oct 20237:00 amRNSAppointment of Independent Non-Executive Director
29th Sep 20237:00 amRNSTrading Update
18th Jul 20237:00 amRNSContract Win
14th Jun 20237:00 amRNSContract Win
23rd May 20237:00 amRNSHalf year report
16th May 20237:00 amRNSInvestor Meet Company presentation
10th May 20237:00 amRNSTrading Update
3rd Apr 20238:35 amRNSExtension of Huntington's disease consortium
21st Mar 202312:11 pmRNSHolding(s) in Company
10th Mar 20237:00 amRNSContract Win
7th Feb 20237:00 amRNSTrading Update
31st Jan 20234:35 pmRNSPrice Monitoring Extension
31st Jan 20232:05 pmRNSSecond Price Monitoring Extn
31st Jan 20232:00 pmRNSPrice Monitoring Extension
31st Jan 202311:05 amRNSSecond Price Monitoring Extn
31st Jan 202311:00 amRNSPrice Monitoring Extension
27th Jan 20231:00 pmRNSResult of AGM
3rd Jan 20237:00 amRNSTotal Voting Rights
22nd Dec 202212:18 pmRNSDirector Bed & ISA Dealing
13th Dec 20227:00 amRNSPDMR Exercise of Options
9th Dec 20229:05 amRNSContract Win
8th Dec 20223:34 pmRNSContract Update
7th Dec 20227:00 amRNSFinancial Results for the year ended 30 Sept 2022
21st Nov 20227:00 amRNSNotice of Results and Investor Presentation
25th Oct 20227:00 amRNSTrading Update
21st Sep 202210:35 amRNSHD-IH Consortium
14th Sep 20227:00 amRNSGrant of Share Options
1st Sep 20227:00 amRNSTrading Update and FY2023 Guidance
4th Aug 20227:00 amRNSContract Win
26th Jul 202211:22 amRNSContract Win - Replacement
21st Jul 20227:00 amRNSContract Win
14th Jun 20227:00 amRNSContract Extension
24th May 20227:00 amRNSHalf-year Report and Trading Update
16th May 20227:00 amRNSInvestor Presentation
10th May 20227:00 amRNSConsortium Agreement in Huntington's Disease
25th Apr 20227:00 amRNSTrading Update
21st Apr 20227:00 amRNSNew Contract Win
8th Mar 20227:00 amRNSContract worth circa £800k
14th Feb 20227:00 amRNSLaunch of IXIQ.Ai Deep learning AI-based platform

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.